Imipenem and Cilastatin
NDC 63323-349 · Fresenius Kabi USA, LLC
FDA carries 3 listing records for this NDC; the most recent is shown.
Generic nameImipenem and Cilastatin Sodium
Dosage formINJECTION, POWDER, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)IMIPENEM, CILASTATIN SODIUM
Strength250; 250 mg/20mL; mg/20mL
Pharmacologic classCarbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]
Marketing categoryANDA
Packages
63323-349-25 — 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-349-25) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-349-01)
63323-349-93 — 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-349-93) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-349-21)
63323-349-94 — 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-349-94) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-349-41)
Billed under HCPCS
J0743 — Injection, cilastatin sodium; imipenem, per 250 mg Medicare Part B payment limit (ASP + 6%): $6.52
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0006-3516 — imipenem and cilastatin sodium, 44567-705 — Imipenem and Cilastatin, 63323-322 — Imipenem and Cilastatin Sodium